These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 30009188)
41. Current issues in delivering DCs for immunotherapy. Barratt-Boyes SM; Figdor CG Cytotherapy; 2004; 6(2):105-10. PubMed ID: 15203986 [TBL] [Abstract][Full Text] [Related]
42. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy. da Cunha A; Antoniazi Michelin M; Cândido Murta EF Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825 [TBL] [Abstract][Full Text] [Related]
43. Towards a standardized protocol for the generation of monocyte-derived dendritic cell vaccines. Erdmann M; Schuler-Thurner B Methods Mol Biol; 2010; 595():149-63. PubMed ID: 19941110 [TBL] [Abstract][Full Text] [Related]
51. Breaking immunotolerance of tumors: a new perspective for dendritic cell therapy. Rolinski J; Hus I J Immunotoxicol; 2014 Oct; 11(4):311-8. PubMed ID: 24495309 [TBL] [Abstract][Full Text] [Related]
52. Vaccines and melanoma. Ott PA; Fritsch EF; Wu CJ; Dranoff G Hematol Oncol Clin North Am; 2014 Jun; 28(3):559-69. PubMed ID: 24880947 [TBL] [Abstract][Full Text] [Related]
53. Augmented induction of CD8+ cytotoxic T-cell response and antitumor effect by DCs pulsed with virus-like particles packaging with CpG. Song S; Wang Y; Zhang Y; Wang F; He Y; Ren D; Guo Y; Sun S Cancer Lett; 2007 Oct; 256(1):90-100. PubMed ID: 17656012 [TBL] [Abstract][Full Text] [Related]
54. Immunization with heat shock protein 105-pulsed dendritic cells leads to tumor rejection in mice. Yokomine K; Nakatsura T; Minohara M; Kira J; Kubo T; Sasaki Y; Nishimura Y Biochem Biophys Res Commun; 2006 Apr; 343(1):269-78. PubMed ID: 16540092 [TBL] [Abstract][Full Text] [Related]
55. Cancer immunotherapy: novel strategies and clinical experiences. Schmitz M; Bornhäuser M; Ockert D; Rieber EP Trends Immunol; 2002 Sep; 23(9):428-9. PubMed ID: 12200057 [No Abstract] [Full Text] [Related]
57. How much help does a vaccine-induced T-cell response need? Weber JS; Mulé JJ J Clin Invest; 2001 Mar; 107(5):553-4. PubMed ID: 11238555 [No Abstract] [Full Text] [Related]
58. Recent progress in GM-CSF-based cancer immunotherapy. Yan WL; Shen KY; Tien CY; Chen YA; Liu SJ Immunotherapy; 2017 Mar; 9(4):347-360. PubMed ID: 28303764 [TBL] [Abstract][Full Text] [Related]
59. DNA vaccines for cancer too. Yu M; Finn OJ Cancer Immunol Immunother; 2006 Feb; 55(2):119-30. PubMed ID: 16032397 [No Abstract] [Full Text] [Related]
60. Optimal control in a model of dendritic cell transfection cancer immunotherapy. Castiglione F; Piccoli B Bull Math Biol; 2006 Feb; 68(2):255-74. PubMed ID: 16794930 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]